The Center for Devices and Regulation Health (CDRH) of the FDA, issued the FY 2020 and the final guidance list featuring few repeats from last year and new drafts on outcome measures that are reported by the patients and are used in device submission, unique device identification, and remanufacturing.

Formerly, there existed two divided lists- "A-list" draft and final guidances, which are a priority, and "B-list", draft and final guidances, which will be published by the CDRH as resources permit. B-list is comparatively smaller than the A-list.